Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic SyndromeAlan F. List, Emmanuel C. Besa, David P. Steensma et al.|Journal of Clinical Oncology|2012Cited by 175